Hanmi Flu outnumbers Tamiflu in flu medicine market

Published: 2016-12-23 16:29:00
Updated: 2016-12-23 13:59:34

The market share of ‘Hanmi Flu,’ a Korean influenza treatment, exceeded 50%.

According to Hanmi Pharm on the 21st, after the flu watch was alerted, its prescriptions were rapidly increased, which made the market share 54.9% in the first week of December and outnumbered the market share of Tamifl...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.